Frequency of Human Papilloma Virus Occurrence Among Pathological Changes of the Oral Cavity in Kidney Allotransplant Recipients Undergoing Long-Term Pharmacological Immunosuppressive Therapy

• Published in: Transplantation proceedings Vol. 50; no. 6; pp. 1878 - 1880
• Main Authors: Szubińska-Lelonkiewicz, D., Osiak, M., Wychowański, P., Siewert-Gutowska, M., Fiedor, P.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.07.2018
• Subjects: Adult; Aged; Azathioprine - adverse effects; Cyclosporine - adverse effects; Female; Humans; Immunosuppression - methods; Immunosuppressive Agents - adverse effects; Kidney Transplantation - adverse effects; Male; Middle Aged; Mouth - virology; Papillomaviridae; Papillomavirus Infections - epidemiology; Papillomavirus Infections - etiology; Prednisone - adverse effects
• ISSN: 0041-1345; 1873-2623
• DOI: 10.1016/j.transproceed.2018.05.008

Recipients of allotransplants are more susceptible to viral infections, among which the human papilloma virus infection is an independent factor inducing precancerous lesions and cancers of both the anogenital and the cervicocephalic region. The study included a group of 69 allogenic kidney transplantation recipients aged 20 to 70, who were treated with cyclosporine, azathioprine, and prednisone. The patients in whom the macroscopic examination of the oral mucosa revealed lesions were qualified for a biopsy. The infection with human papilloma virus (HPV) was confirmed by a histopathological examination and genotyping with the use of polymerase chain reaction (PCR) and Hybrid Capture II test. Papillomatous lesions in the oral cavity occurred in 36.1% of the research group participants. The HPV16 virus was the most common genotype in this group of patients (25%). The pathologic changes in the oral cavity were predominantly situated on the gingivae. In the group of transplant recipients, clinical changes resulting from HPV infection occurred within a period of 2 years following the transplantation. Cyclosporine used in the immunosuppression scheme has correlated in as many as 53.7% of cases of allogenic kidney transplant recipients with the appearance of clinical signs and symptoms of HPV infection. In 50% of cases there was a correlation with acute kidney transplant rejection. When induction therapy (anti-thymocyte globulin [ATG] and muromonab-CD3 [OKT3]) was applied, at least 1 oral cavity lesion in each case of allogenic transplant recipients was reported. Typing of HPV with the use of molecular methods should be a standard diagnostic technique. •Human papillomavirus (HPV) infection in transplantology is an important clinical and therapeutic problem.•Long-term immunosuppressive therapy is associated with an increased risk of HPV infection.•HPVs are an important and independent risk factor in developing premalignant and malignant lesions in the oral cavity of renal transplant recipients.